• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    NeueHealth to Host First Quarter 2025 Earnings Conference Call on May 8, 2025

    4/23/25 8:00:00 AM ET
    $NEUE
    Medical Specialities
    Health Care
    Get the next $NEUE alert in real time by email

    NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report first quarter financial results before the financial markets open on Thursday, May 8, 2025, followed by a conference call at 8:00 AM Eastern Time.

    To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call.

    A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The company suggests participants for the conference call dial in at least 15 minutes in advance of the call. A recording of the earnings call and presentation will be available on NeueHealth's Investor Relations page following the call.

    About NeueHealth

    NeueHealth is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. NeueHealth delivers high-quality clinical care to over 700,000 health consumers through owned clinics and unique partnerships with over 3,000 affiliated providers. We also enable independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally. We believe our value-driven, consumer-centric care model can transform the healthcare experience and maximize value across the healthcare ecosystem. For more information, visit: www.neuehealth.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250423813369/en/

    Investor Contact

    [email protected]

    Media Contact

    [email protected]

    Get the next $NEUE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NEUE

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NEUE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • NeueHealth Reports First Quarter 2025 Results

      Delivered strong first quarter performance as care model continues to resonate with consumers, providers, and payors across the healthcare industry Drove positive Adjusted EBITDA for the fifth consecutive quarter, providing a strong foundation for continued success in 2025 and beyond Served approximately 709,000 consumers, an increase of 51% over the first quarter of 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its first quarter ended March 31, 2025. "We are starting 2025 in a very strong position, generating substantial growth in the number of consumers we serve and delivering another

      5/8/25 6:45:00 AM ET
      $NEUE
      Medical Specialities
      Health Care
    • NeueHealth to Host First Quarter 2025 Earnings Conference Call on May 8, 2025

      NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report first quarter financial results before the financial markets open on Thursday, May 8, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The company suggests participant

      4/23/25 8:00:00 AM ET
      $NEUE
      Medical Specialities
      Health Care
    • NeueHealth Reports Fourth Quarter and Full Year 2024 Results

      Delivered strongest financial performance to date in 2024, resulting from continued success of value-driven, consumer-centric care model Drove positive Adjusted EBITDA for the fourth consecutive quarter in 2024, establishing the foundation for continued strong performance in 2025 and beyond Generated significant growth to start 2025, serving 717,000 consumers, an increase of 48% compared to 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2024. "In 2024, we delivered our strongest financial performance to date, demonstrating the power of our

      3/20/25 6:45:00 AM ET
      $NEUE
      Medical Specialities
      Health Care

    $NEUE
    SEC Filings

    See more
    • SEC Form 10-Q filed by NeueHealth Inc.

      10-Q - NeueHealth, Inc. (0001671284) (Filer)

      5/9/25 6:34:33 AM ET
      $NEUE
      Medical Specialities
      Health Care
    • NeueHealth Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - NeueHealth, Inc. (0001671284) (Filer)

      5/8/25 5:11:35 PM ET
      $NEUE
      Medical Specialities
      Health Care
    • NeueHealth Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - NeueHealth, Inc. (0001671284) (Filer)

      5/8/25 6:46:30 AM ET
      $NEUE
      Medical Specialities
      Health Care

    $NEUE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by NeueHealth Inc. (Amendment)

      SC 13D/A - NeueHealth, Inc. (0001671284) (Subject)

      4/10/24 9:52:09 PM ET
      $NEUE
      Medical Specialities
      Health Care

    $NEUE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Accounting Officer Scherman Jeffrey J sold $9,039 worth of shares (1,373 units at $6.58), decreasing direct ownership by 10% to 12,234 units (SEC Form 4)

      4 - NeueHealth, Inc. (0001671284) (Issuer)

      3/17/25 8:40:45 PM ET
      $NEUE
      Medical Specialities
      Health Care
    • GC & Corporate Secretary Craig Jeffery Michael sold $23,001 worth of shares (3,494 units at $6.58), decreasing direct ownership by 15% to 20,104 units (SEC Form 4)

      4 - NeueHealth, Inc. (0001671284) (Issuer)

      3/17/25 8:39:34 PM ET
      $NEUE
      Medical Specialities
      Health Care
    • EVP, Consumer Care Orozco Tomas sold $31,375 worth of shares (4,766 units at $6.58), decreasing direct ownership by 14% to 29,325 units (SEC Form 4)

      4 - NeueHealth, Inc. (0001671284) (Issuer)

      3/17/25 8:38:23 PM ET
      $NEUE
      Medical Specialities
      Health Care

    $NEUE
    Financials

    Live finance-specific insights

    See more
    • NeueHealth Reports First Quarter 2025 Results

      Delivered strong first quarter performance as care model continues to resonate with consumers, providers, and payors across the healthcare industry Drove positive Adjusted EBITDA for the fifth consecutive quarter, providing a strong foundation for continued success in 2025 and beyond Served approximately 709,000 consumers, an increase of 51% over the first quarter of 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its first quarter ended March 31, 2025. "We are starting 2025 in a very strong position, generating substantial growth in the number of consumers we serve and delivering another

      5/8/25 6:45:00 AM ET
      $NEUE
      Medical Specialities
      Health Care
    • NeueHealth to Host First Quarter 2025 Earnings Conference Call on May 8, 2025

      NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report first quarter financial results before the financial markets open on Thursday, May 8, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The company suggests participant

      4/23/25 8:00:00 AM ET
      $NEUE
      Medical Specialities
      Health Care
    • NeueHealth Reports Fourth Quarter and Full Year 2024 Results

      Delivered strongest financial performance to date in 2024, resulting from continued success of value-driven, consumer-centric care model Drove positive Adjusted EBITDA for the fourth consecutive quarter in 2024, establishing the foundation for continued strong performance in 2025 and beyond Generated significant growth to start 2025, serving 717,000 consumers, an increase of 48% compared to 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2024. "In 2024, we delivered our strongest financial performance to date, demonstrating the power of our

      3/20/25 6:45:00 AM ET
      $NEUE
      Medical Specialities
      Health Care